A 12-member steering committee co-chaired by Claridge CEO Pierre Boivin and UdeM Rector Guy Breton will guide the process.
Julie Hlavacek-Larrondo and Marie-Lou Gendron Marsolais, two researchers at Université de Montréal and the CRAQ, helped find the phenomenon through their work on radio waves.
A Trump Dividend for Canada? Maybe in Its A.I. Industry
For his doctorate, Sylvain Gaudet is studying how to help athletes cut down on injuries during training.
For her doctorate, Valentine Crosset is probing how the terrorist group goes about creating and organizing its online propaganda.
Morgane Bonamy hopes these misunderstood carnivores will someday be reintroduced to their natural habitat in northern Quebec.
Julie Saint-Laurent studies post-traumatic stress disorder among workers who’ve returned from abroad.
For his doctorate, Simon Laperrière explores the phenomenon of “fan theories” about major feature movies.
As part of his PhD, Vincent Denault explores why witnesses lie in court.
New research has discovered that a common genetic defect in beta cells may underlie both known forms of diabetes.
"It is important to change our mentalities and behaviours with regard to sexual violence."
Research team now provide a new mechanism for that blinding retinal disease that debunk the scientific beliefs surrounding the cause of abnormal proliferation of blood vessels leading to blindness.
Findings recently published in The Journal of Sex Research contradict the DSM-5, as they demonstrate that a number of legal sexual interests and behaviors considered anomalous in psychiatry are actual
A team of researchers have just identified a small molecule, miR-137, involved in the development of pancreatic cancer, one of the relentless cancers.
Researchers have just released a new interactive tool to visualize, with unprecedented detail, the geographic distribution of climate opinions across Canada.
Young adults in their twenties who regularly binge drink have higher blood pressure which may increase the risk of developing hypertension, concludes a new study.
The FDA grants a Fast Track designation for a treatment for primary mitochondrial myopathy.
Drugs approved to treat heart failure, cardiac arrhythmia, and infections showed promising perspectives in treating cancers.
A new approach gives promising results for the treatment of multiple myeloma, considered incurable with conventional chemotherapy, resulted in a total cure rate of 41%, a record level.